Skip to main content
Livermore
Livermore
ZHEN

Profund Advisors LLC

SEC CIK
0001129919
Latest filing
Aug 11, 2026

RARE holding history

Ultragenyx Pharmaceutical Inc. in every 13F filed by Profund Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

RARE overviewAll 13F holders of RAREFull Q2 2026 holdings

Shares (Q2 2026)
51,450
Value
$1.72M
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of RARE by Profund Advisors LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202651,450$1.72M<0.1%−20,658−28.6%ReducedHolders
Q1 202672,108$1.51M0.1%+15,484+27.3%AddedHolders
Q4 202556,624$1.30M<0.1%+24,360+75.5%AddedHolders
Q3 202532,264$970.5K<0.1%+16,098+99.6%AddedHolders
Q2 202516,166$587.8K<0.1%−1,414−8.0%ReducedHolders
Q1 202517,580$636.6K<0.1%−1,011−5.4%ReducedHolders
Q4 202418,591$782.1K<0.1%−22−0.1%ReducedHolders
Q3 202418,613$1.03M<0.1%−3,788−16.9%ReducedHolders
Q2 202422,401$920.7K<0.1%−5,083−18.5%ReducedHolders
Q1 202427,484$1.28M<0.1%−7,531−21.5%ReducedHolders
Q4 202335,015$1.67M0.1%+4,954+16.5%AddedHolders
Q3 202330,061$1.07M0.1%+1,355+4.7%AddedHolders
Q2 202328,706$1.32M0.1%−3,195−10.0%ReducedHolders
Q1 202331,901$1.28M0.1%+24,081+307.9%AddedHolders
Q4 20227,820$362.3K<0.1%+183+2.4%AddedHolders
Q3 20227,637$316.0K<0.1%−353−4.4%ReducedHolders
Q2 20227,990$477.0K<0.1%−501−5.9%ReducedHolders
Q1 20228,491$617.0K<0.1%−881−9.4%ReducedHolders
Q4 20219,372$788.0K<0.1%−1,628−14.8%ReducedHolders
Q3 202111,000$992.0K<0.1%+173+1.6%AddedHolders
Q2 202110,827$1.03M<0.1%−2,201−16.9%ReducedHolders
Q1 202113,028$1.48M0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.